STOCK TITAN

Zomedica to Report Fourth Quarter and Full Year 2024 Financial Results with a Business Update on March 13th at 4:30 p.m. ET

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
conferences earnings

Zomedica (NYSE American:ZOM) has scheduled its Fourth Quarter and Full Year 2024 Financial Results conference call and audio webcast for March 13, 2025, at 4:30 p.m. ET. The veterinary health company, which specializes in point-of-care diagnostic and therapeutic products for equine and companion animals, will present operational and financial highlights followed by a Q&A session.

Interested participants can join via phone at +1-800-717-1738 (U.S. Toll-Free) or +1-646-307-1865 (International). A replay will be available until March 27, 2025, at 11:59 PM ET by dialing +1-844-512-2921 (U.S. Toll-Free) or +1-412-317-6671 (International) with pin number: 1174148.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

-4.33% News Effect

On the day this news was published, ZOM declined 4.33%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

ANN ARBOR, MI / ACCESS Newswire / February 26, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, will host a conference call and audio-only webcast on Thursday, March 13, 2025, at 4:30 p.m. ET to discuss the Company's operational and financial highlights for its fourth quarter and full year ended December 31, 2024. A question-and-answer session will follow management's prepared remarks.

Event: Zomedica Corp. Q4 and FY 2024 Financial Results Conference Call

Date: Thursday, March 13, 2025

Time: 4:30 p.m. Eastern Time

Live Call: +1-800-717-1738 (U.S. Toll-Free) or +1-646-307-1865 (International)

Webcast: LINK

For interested individuals unable to join the conference call, a dial-in replay of the call will be available until Thursday, March 27, 2025 at 11:59 PM ET and can be accessed by dialing +1-844-512-2921 (U.S. Toll-Free) or +1-412-317-6671 (International) and entering replay pin number: 1174148

About Zomedica

Zomedica is a leading equine and companion animal healthcare company dedicated to improving animal health by providing veterinarians innovative therapeutic and diagnostic solutions. Our gold standard PulseVet® shock wave system, which accelerates healing in musculoskeletal conditions, has transformed veterinary therapeutics. Our suite of products also includes the Assisi® Loop line of therapeutic devices and the TRUFORMA® diagnostic platform, the TRUVIEW™ digital cytology system, and the VetGuardian® no-touch monitoring system, all designed to empower veterinarians to provide top-tier care. In the aggregate, their total addressable market in the U.S. exceeds $2 billion. Headquartered in Michigan, Zomedica employs approximately 150 people and manufactures and distributes its products from its world-class facilities in Georgia and Minnesota. An NYSE American company, Zomedica grew revenue 33% in 2023 to $25 million and maintains a strong balance sheet with approximately $78 million in liquidity as of September 30, 2024. Zomedica is advancing its product offerings, leveraging strategic acquisitions, and expanding internationally as we work to enhance the quality of care for pets, increase pet parent satisfaction, and improve the workflow, cash flow and profitability of veterinary practices. For more information visit www.zomedica.com.

Follow Zomedica

Email Alerts: http://investors.zomedica.com
LinkedIn: https://www.linkedin.com/company/zomedica
X (formerly Twitter): https://x.com/zomedica
Facebook: https://m.facebook.com/zomedica
Instagram: https://www.instagram.com/zomedica_inc

Investor Relations Contact:

Zomedica Investor Relations
investors@zomedica.com
1-734-369-2555

SOURCE: Zomedica Corp.



View the original press release on ACCESS Newswire

FAQ

When will Zomedica (ZOM) release its Q4 and FY 2024 earnings?

Zomedica will release its Q4 and FY 2024 earnings on March 13, 2025, at 4:30 p.m. ET.

How can investors join Zomedica's (ZOM) Q4 2024 earnings call?

Investors can join via phone at +1-800-717-1738 (U.S.) or +1-646-307-1865 (International), or through the webcast.

Until when is the replay of ZOM's Q4 2024 earnings call available?

The earnings call replay will be available until March 27, 2025, at 11:59 PM ET.

What is the replay pin number for Zomedica's (ZOM) Q4 2024 earnings call?

The replay pin number is 1174148.
Zomedica Corp

NYSE:ZOM

ZOM Rankings

ZOM Latest News

ZOM Latest SEC Filings

ZOM Stock Data

120.44M
961.51M
Pharmaceutical Preparation Manufacturing
Pharmaceutical Preparations
Link
US
ANN ARBOR